Outcome analysis of cervical adenosquamous carcinoma compared with adenocarcinoma

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 10, 2012, Pages 1158-1166

  Chen, Jenny Ling Yu ^a   Cheng, Jason Chia Hsien ^a   Kuo, Sung Hsin ^a   Chen, Chi An ^b   Lin, Ming Chieh ^b   Huang, Chao Yuan ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

adenocarcinoma; adenosquamous carcinoma; Cervical cancer; concurrent chemoradiotherapy; radiotherapy; surgery; Taiwan

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CERVICAL ADENOSQUAMOUS CARCINOMA; CHEMORADIOTHERAPY; COMPARATIVE STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; METASTASIS; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREGNANCY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TAIWAN; TUMOR DIFFERENTIATION; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, ADENOSQUAMOUS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84866509515     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2012.01420.x     Document Type: Article

References (15)

1. Waggoner SE,. Cervical cancer. Lancet. 2003; 361: 2217-25.
2. Gien LT, Beauchemin MC, Thomas G,. Adenocarcinoma: a unique cervical cancer. Gynecol Oncol. 2010; 116: 140-6.
3. Sasieni P, Adams J,. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet. 2001; 357: 1490-3.
4. Huang CY, You SL, Chen CJ, Cheng WF, Luo HC, Hsieh CY,. Incidence of cervical cancer and age-specific survival of small cell cervical carcinoma in Taiwan. Acta Obstet Gynecol Scand. 2011; 90: 1342-9.
5. Chen RJ, Lin YH, Chen CA, Huang SC, Chow SN, Hsieh CY,. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Gynecol Oncol. 1999; 73: 184-90.
6. Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA,. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer. 2003; 97: 2196-202.
7. Look KY, Brunetto VL, Clarke-Pearson DL, Averette HE, Major FJ, Alvarez RD, et al,. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1996; 63: 304-11.
8. dos Reis R, Frumovitz M, Milam MR, Capp E, Sun CC, Coleman RL, et al,. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. Gynecol Oncol. 2007; 107: 458-63.
9. Harrison TA, Sevin BU, Koechli O, Nguyen HN, Averette HE, Penalver M, et al,. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy. Gynecol Oncol. 1993; 50: 310-5.
10. Chen RJ, Chang DY, Yen ML, Lee EF, Huang SC, Chow SN, et al,. Prognostic factors of primary adenocarcinoma of the uterine cervix. Gynecol Oncol. 1998; 69: 157-64.
11. Zaino RJ,. Glandular lesions of the uterine cervix. Mod Pathol. 2000; 13: 261-74.
12. Haines M, Taylor CW, Fox H, Wells M,. Haines and Taylor obstetrical and gynaecological pathology, 5th edn. Edinburgh: Churchill Livingstone, 2003.
13. Lawrence WD, Abdul-Karim FW, Crum C, Fu YS,. Recommendations for the reporting of surgical specimens containing uterine cervical neoplasms. Association of Directors of Anatomic and Surgical Pathology. Hum Pathol. 2000; 31: 1194-8.
14. Wang SS, Sherman ME, Silverberg SG, Carreon JD, Lacey JV Jr, Zaino R, et al,. Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study. Gynecol Oncol. 2006; 103: 541-6.
15. Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH, et al,. Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2011; 80: 429-36.